Most cited papers from Klinikum Bremen-Mitte

Klinikum Bremen-Mitte

What are the most cited papers from Klinikum Bremen-Mitte?

The most cited paper from Klinikum Bremen-Mitte is "Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma" (Dominik Sturm et al., 2012), with 1,881 citations. Next come "Cortical demyelination and diffuse white matter injury in multiple sclerosis" (1,857) and "Diagnostic criteria for malnutrition – An ESPEN Consensus Statement" (1,770).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 183 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma Dominik Sturm et al. · Cancer Cell Open access	Oct 2012	1,881
2	Cortical demyelination and diffuse white matter injury in multiple sclerosis Alexandra Kutzelnigg, Claudia Francesca Lucchinetti, Christine Stadelmann et al. · Brain	17 Oct 2005	1,857
3	Diagnostic criteria for malnutrition – An ESPEN Consensus Statement Tommy Cederholm, Ingvar G. Bosaeus, Rocco Barazzoni et al. · Clinical Nutrition Open access	9 Mar 2015	1,770
4	Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia Willemijn J. Jansen et al. · JAMA Open access129 authors	19 May 2015	1,662
5	ESPEN expert group recommendations for action against cancer-related malnutrition Jann Arends, Vickie Elaine Baracos, Hartmut Bertz et al. · Clinical Nutrition Open access	23 Jun 2017	1,326
6	Skin Wound Healing: An Update on the Current Knowledge and Concepts Heiko Sorg, Daniel J. Tilkorn, Stephan Hager et al. · European Surgical Research Open access	14 Dec 2016	1,274
7	Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis Daniel J. Lovell et al. · New England Journal of Medicine Open access	20 Aug 2008	635
8	High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial Eckhard Thiel et al. · The Lancet Oncology	22 Oct 2010	626
9	Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial Andrés J.M. Ferreri et al. · The Lancet Haematology Open access	9 Apr 2016	612
10	Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke Hannelore Ehrenreich et al. · Stroke Open access	15 Oct 2009	601
11	Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial Martin Bendszus et al. · The Lancet 449 authors	11 Oct 2023	473
12	Comparison of Basal Insulin Added to Oral Agents Versus Twice-Daily Premixed Insulin as Initial Insulin Therapy for Type 2 Diabetes Hans Uwe Janka, G. Plewe, Matthew C. Riddle et al. · Diabetes Care Open access	Feb 2005	414
13	PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group Peter Borchmann et al. · The Lancet	23 Oct 2017	394
14	Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial Andrés J.M. Ferreri et al. · The Lancet Haematology Open access	18 Oct 2017	390
15	Infection-Triggered Familial or Recurrent Cases of Acute Necrotizing Encephalopathy Caused by Mutations in a Component of the Nuclear Pore, RANBP2 Derek Neilson et al. · The American Journal of Human Genetics Open access	2009	368
16	ESPEN guideline on Clinical Nutrition in inflammatory bowel disease Stephan C. Bischoff, Palle Bager, Johanna C. Escher et al. · Clinical Nutrition Open access	13 Jan 2023	365
17	Mutations in STRA6 Cause a Broad Spectrum of Malformations Including Anophthalmia, Congenital Heart Defects, Diaphragmatic Hernia, Alveolar Capillary Dysplasia, Lung Hypoplasia, and Mental Retardation Francesca Pasutto et al. · The American Journal of Human Genetics Open access	5 Feb 2007	363
18	Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study Klaus‐Peter Dieckmann et al. · Journal of Clinical Oncology Open access	15 Mar 2019	354
19	Indirect methods for reference interval determination – review and recommendations Graham R.D. Jones, Rainer Haeckel, Tze Ping Loh et al. · Clinical Chemistry and Laboratory Medicine (CCLM)	19 Apr 2018	353
20	Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group Dominik Paul Modest, Ingrid Ricard, Volker Heinemann et al. · Annals of Oncology Open access	29 Jun 2016	353
21	Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer Michael Thomas, Christian Rübe, Petra Hoffknecht et al. · The Lancet Oncology	25 Jun 2008	348
22	Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants for the SAKK and the German CML Study Group et al. · Leukemia Open access	14 Aug 2017	342
23	Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study Samantha Claudia Gouw et al. · Blood	4 Apr 2013	331
24	Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study Jan Menne et al. · BMJ Open access	19 Jul 2012	310
25	A de novo gain-of-function mutation in SCN11A causes loss of pain perception Enrico Leipold et al. · Nature Genetics	15 Sep 2013	309
26	Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity Eleonore D. Renner, Jennifer M. Puck, Steven M. Holland et al. · The Journal of Pediatrics	2004	302
27	Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial Dieter F. Hoelzer et al. · Blood Open access	31 Oct 2014	299
28	ESPEN guideline on clinical nutrition in acute and chronic pancreatitis Marianna Arvanitakis, Johann Ockenga, Mihailo Bezmarević et al. · Clinical Nutrition Open access	22 Jan 2020	291
29	Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD Richard F. Schlenk et al. · Blood Open access	18 Dec 2018	290
30	Cerebral Microbleeds in CADASIL Martin Dichgans, Markus Holtmannspötter, Jürgen Herzog et al. · Stroke Open access	2002	288
31	Endovascular Treatment for Stroke Due to Occlusion of Medium or Distal Vessels Marios‐Nikos Psychogios et al. · New England Journal of Medicine Open access	5 Feb 2025	260
32	Treatment and prognostic impact of transient leukemia in neonates with Down syndrome Jan‐Henning Klusmann, Ursula Creutzig, Martin Zimmermann et al. · Blood Open access	9 Jan 2008	259
33	Functional Outcome Following Stroke Thrombectomy in Clinical Practice Frank Arne Wollenweber et al. · Stroke Open access	24 Jul 2019	255
34	S3-Leitlinie – Kolorektales Karzinom Wolff Schmiegel, Barbara Buchberger, Markus Follmann et al. · Zeitschrift für Gastroenterologie Open access	Dec 2017	244
35	Cetuximab plus cisplatin–5-fluorouracil versus cisplatin–5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie Sylvie Lorenzen, Tibor Schuster, Rainer Porschen et al. · Annals of Oncology Open access	24 Jun 2009	243
36	Agreement of different methods for assessing sleep characteristics: a comparison of two actigraphs, wrist and hip placement, and self-report with polysomnography Melanie Zinkhan, Klaus Berger, Sabrina Hense et al. · Sleep Medicine	28 May 2014	243
37	Oncogenic FAM131B–BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma Huriye Cin et al. · Acta Neuropathologica	19 Mar 2011	240
38	Man against machine reloaded: performance of a market-approved convolutional neural network in classifying a broad spectrum of skin lesions in comparison with 96 dermatologists working under less artificial conditions Holger Andreas Haenssle et al. · Annals of Oncology Open access	2020	239
39	Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the German STEC-HUS registry Jan Thomas Kielstein et al. · Nephrology Dialysis Transplantation	Oct 2012	239
40	Positron Emission Tomography–Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group Michael Fuchs et al. · Journal of Clinical Oncology	9 Sep 2019	233
41	PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups Lars Henning Schmidt, Andreas Kümmel, Dennis Görlich et al. · PLoS ONE Open access	27 Aug 2015	232
42	Working memory related gamma oscillations in schizophrenia patients Canan Başar‐Eroğlu, Andreas Brand, Helmut Hildebrandt et al. · International Journal of Psychophysiology	8 Sep 2006	229
43	e-ASPECTS software is non-inferior to neuroradiologists in applying the ASPECT score to computed tomography scans of acute ischemic stroke patients Simon Nagel et al. · International Journal of Stroke Open access	29 Nov 2016	218
44	Retinopathy and Vision Loss in Insulin-dependent Diabetes in Europe Anne Katrin Sjølie et al. · Ophthalmology 127 authors	Feb 1997	216
45	Distinguishing reference intervals and clinical decision limits – A review by the IFCC Committee on Reference Intervals and Decision Limits Yeşim Özarda, Ken A. Sikaris, Thomas Streichert et al. · Critical Reviews in Clinical Laboratory Sciences Review	26 Jul 2018	212
46	Diagnostic Accuracy of Plasma Glial Fibrillary Acidic Protein for Differentiating Intracerebral Hemorrhage and Cerebral Ischemia in Patients with Symptoms of Acute Stroke Christian Foerch, Marion Niessner, Tobias Back et al. · Clinical Chemistry	29 Nov 2011	211
47	Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours Klaus‐Peter Dieckmann, Arlo Radtke, Meike Spiekermann et al. · European Urology Open access	3 Aug 2016	210
48	Quality of Life in orthognathic surgery patients: Post-surgical improvements in aesthetics and self-confidence Jan Rustemeyer, Johanne Gregersen · Journal of Cranio-Maxillofacial Surgery	28 Aug 2011	200
49	18F-FDG PET for Mediastinal Staging of Lung Cancer: Which SUV Threshold Makes Sense? Dirk Hellwig, Thomas P Graeter, D. Ukena et al. · Journal of Nuclear Medicine Open access	17 Oct 2007	199
50	Pathway-controlled fast-track rehabilitation after total knee arthroplasty: a randomized prospective clinical study evaluating the recovery pattern, drug consumption, and length of stay Adrianus den Hertog, Kerstin Gliesche, Jürgen Timm et al. · Archives of Orthopaedic and Trauma Surgery Open access	27 May 2012	198

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.